KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-Current Debt (2016 - 2020)

Neogenomics' Non-Current Debt history spans 8 years, with the latest figure at $90.6 million for Q1 2020.

  • For Q1 2020, Non-Current Debt rose 5.36% year-over-year to $90.6 million; the TTM value through Mar 2020 reached $90.6 million, up 5.36%, while the annual FY2019 figure was $91.8 million, 1736.58% up from the prior year.
  • Non-Current Debt reached $90.6 million in Q1 2020 per NEO's latest filing, down from $91.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $93.0 million in Q3 2019 to a low of $5.0 million in Q4 2018.
  • Average Non-Current Debt over 5 years is $58.1 million, with a median of $66.6 million recorded in 2017.
  • Peak YoY movement for Non-Current Debt: tumbled 92.49% in 2018, then soared 1736.58% in 2019.
  • A 5-year view of Non-Current Debt shows it stood at $70.1 million in 2016, then decreased by 5.04% to $66.6 million in 2017, then crashed by 92.49% to $5.0 million in 2018, then skyrocketed by 1736.58% to $91.8 million in 2019, then fell by 1.33% to $90.6 million in 2020.
  • Per Business Quant, the three most recent readings for NEO's Non-Current Debt are $90.6 million (Q1 2020), $91.8 million (Q4 2019), and $93.0 million (Q3 2019).